Slovenian drugmaker Krka to set up China joint venture

Krka dd Novo Mesto

21/09/2017 09:25

LJUBLJANA, Sept 21 (Reuters) - Slovenian generic drugs 
producer Krka  KRKG.LJ  said it will form a joint venture in 
China and take a majority stake. 
    The company will be formed in the coming months, Krka said 
in a statement on Thursday, giving no further details.  
    In July it said it was in talks to buy a small Chinese 
pharmaceutical company which has sales of less than 10 million 
euros ($11.9 mln) a year.  urn:newsml:reuters.com:*:nL8N1JX3JX 
    Krka is Slovenia's largest listed firm with a market 
capitalisation of about 1.8 billion euros.  
    Following its announcement on Thursday its shares were up 
0.9 percent at 55.6 euros by 0810 GMT, outperforming a 0.2 
percent rise in Slovenia's blue-chip SBI index  .SBITOP . 
  
 ($1 = 0.8400 euros) 
 
 (Reporting By Marja Novak; Editing by Susan Fenton) 
 ((Marja.Novak@thomsonreuters.com; +386-1-5058805, Reuters 
Messaging: marja.novak.thomsonreuters.com@reuters.net)) 
 
Keywords: KRKA CHINA/